Dr. Reddy's Slides 1.05% to 1,279.70 Rupees as Sensex Falls 1.70%

15 articles · Updated · MarketWatch · May 11

Dr. Reddy's Laboratories fell 1.05% to 1,279.70 rupees on Monday, a milder drop than the broader Indian market's selloff.
The BSE Sensex lost 1.70% to 76,015.28 in a rough session, helping drive the stock lower while leaving it relatively resilient versus the benchmark.
The shares finished 7.13% below their 52-week high of 1,377.95 rupees, reached on June 12.
Among peers, Lupin dropped 5.19% while Zydus Lifesciences rose 1.80% and Wockhardt gained 1.19%, underscoring mixed pharma trading.
Volume was light at 47,674 shares against a 50-day average of 94,384, suggesting limited conviction behind the move.

Amidst bearish ratings, can Dr. Reddy's pivot to specialty drugs overcome its looming generic revenue cliff?

Will regulatory hurdles and competition derail Dr. Reddy's high-stakes bet on its generic Ozempic blockbuster?